Related Experiment Video
Updated: May 31, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
IBD in transition: a decade of data from the Malaysian Kinta Valley cohort
Ida Hilmi1, Xin-Hui Khoo1, David Yi-Vern Kwong1
1Department of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia.
Background And Aims:
Inflammatory bowel disease (IBD) is emerging in the Asia-Pacific region including Malaysia. The aim of this study is to compare the current incidence and prevalence of IBD in Malaysia from the previous decade, as well as comparing the incidence rates between the urban and rural population.
Methods:
Kinta Valley was selected as the urban catchment area while Hilir Perak was selected for the rural catchment area within the same state. Patients newly diagnosed with IBD were prospectively recruited, and all confirmed IBD cases were included for the prevalence analysis. Baseline demographic information and disease characteristics were recorded.
Results:
The crude incidence rates of IBD, ulcerative colitis (UC), Crohn disease (CD) and IBD unclassified (IBD-U) in Kinta Valley were 1.13, 0.45, 0.60, and 0.08 per 100 000 person-years, respectively, compared to 0.68, 0.46, and 0.20 per 100 000 person-years in 2013. The incidence of UC:CD was 0.75:1 compared to 2.3:1 from the previous study. The prevalence rates were 15.08, 10.13, 4.84, and 0.11 for IBD, CD, UC, and IBD-U per 100 000 population, respectively. The matching incidence rates in a nearby rural area were higher, at 3.29, 1.88, 1.41, and 0.47 per 100 000 person-years, respectively, but the overall incident cases were very low.
Conclusion:
Our findings suggest an increasing incidence of IBD in Malaysia, in keeping with the second stage of the global evolution of IBD. There is a potential shift in the relative incidence of CD compared to UC, but larger population studies are required for confirmation.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

